AIMA
CC icon

Ables Iannone Moore & Associates’s Chemours CC Stock Holding History

Ables Iannone Moore & Associates’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,150
Closed -$99.4K – 107
2023
Q4 		$99.4K Buy
+3,150
New +$85.5K 0.08% 69

Other funds holding CC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
VNIM
Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ables Iannone Moore & Associates's CC Position: Q1 2024 in Review

Ables Iannone Moore & Associates sold out of Chemours (CC) in Q1 2024, closing a stake of 3,150 shares — an estimated $99.4K sold.

Ables Iannone Moore & Associates first reported a position in CC in Q4 2023 and held it in 1 quarter. The position peaked at $99.4K in Q4 2023. 443 funds tracked by Wall St. Rank hold CC as of Q1 2024.

  • Ables Iannone Moore & Associates reported no remaining Chemours position as of Q1 2024 after selling out during the quarter.
  • Ables Iannone Moore & Associates sold 3,150 Chemours shares in Q1 2024, an estimated $99.4K.
  • Ables Iannone Moore & Associates first reported a position in Chemours in Q4 2023 and held it in 1 quarter.
  • Ables Iannone Moore & Associates's Chemours position peaked at $99.4K in Q4 2023.
  • 443 funds tracked by Wall St. Rank held Chemours as of Q1 2024.

Based on Ables Iannone Moore & Associates's 13F filing for Q1 2024, filed 30 Apr 2024.